The results from this pathway analysis along with other features, such as high levels of both MYC and BCL-2 expression, accelerated aggressive tumour onset, positive CD19 expression and monoclonal tumour types, reveals that our murine lymphoma model fulfils many criteria of a classical DHL despite not being of GC origin. The gene discussed is MYC; the disease is lymphoma.